SRAM
ADMA icon

Spouting Rock Asset Management’s ADMA Biologics ADMA Stock Holding History

Spouting Rock Asset Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$83.2K Buy
+18,399
New +$68.1K 0.03% 116

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Spouting Rock Asset Management's ADMA Position: Q4 2023 in Review

Spouting Rock Asset Management opened a new position in ADMA Biologics (ADMA) in Q4 2023: 18,399 shares worth $83.2K. The stake represents 0.03% of the portfolio and ranks #116 among its holdings.

184 funds tracked by Wall St. Rank hold ADMA as of Q4 2023.

  • Spouting Rock Asset Management held 18,399 shares of ADMA Biologics worth $83.2K as of Q4 2023.
  • ADMA Biologics was a new Spouting Rock Asset Management position in Q4 2023.
  • ADMA Biologics made up 0.03% of Spouting Rock Asset Management's portfolio in Q4 2023, its #116 holding.
  • 184 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2023.

Based on Spouting Rock Asset Management's 13F filing for Q4 2023, filed 16 Feb 2024.